Truist lowered the firm’s price target on Cigna (CI) to $375 from $390 and keeps a Buy rating on the shares. The firm is adjusting its model after the company’s Q4 earnings miss, also cutting its FY25 EPS view to $29.58 from $31.40 and its FY26 view to $33.10 from $35.14, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CI: